< ERA 2024 | Vera Therapeutics

This site is intended for US healthcare professionals.

Cover Image
igAN

European Renal Association (ERA) 2024

Stockholm, Sweden
May 23-26, 2024
Abstract and Poster
  • Impact of Atacicept on Hematuria in IgA Nephropathy: Post-Hoc Analysis of the Phase 2b ORIGIN Study

    Floege J, et al.

Abstract and Oral Presentation
  • Phase 2b ORIGIN Study Open Label Extension With Atacicept in Patients With IgA Nephropathy and Persistent Proteinuria: Week 72 Interim Analysis

    Lafayette R, et al.

Industry-Sponsored Symposium
  • Targeting the Source of IgA Nephropathy: Focus on BAFF and APRIL Pathways

    Presented by: Dr. Chee Kay Cheung, Dr. Heather Reich, and Dr. Jürgen Floege